{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:31:12Z","timestamp":1790958672043,"version":"4.1.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.semcancer.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:15:08Z","timestamp":1626178508000},"page":"753-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"P3","title":["Recent advances in microbial toxin-related strategies to combat cancer"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-3855","authenticated-orcid":false,"given":"Prabodh Chander","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5539-7090","authenticated-orcid":false,"given":"Madhulika","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0790-2264","authenticated-orcid":false,"given":"Vijay Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-3058","authenticated-orcid":false,"given":"Jitender Kumar","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh K.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2021.07.007_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/eri.09.42","article-title":"Microbial toxins: current research and future trends","volume":"7","author":"Mohamadzadeh","year":"2009","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0010","doi-asserted-by":"crossref","first-page":"123379","DOI":"10.1016\/j.jhazmat.2020.123379","article-title":"Advances in nanomaterial-based electrochemical biosensors for the detection of microbial toxins, Pathogenic bacteria in food matrices","volume":"401","author":"Gupta","year":"2020","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0015","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.str.2010.04.018","article-title":"Crystal structures of Phd-Doc, HigA, and YeeU establish multiple evolutionary links between microbial growth-regulating toxin-antitoxin systems","volume":"18","author":"Arbing","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0020","series-title":"The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer: End Result in 449 Cases","author":"Nauts","year":"1980"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0025","first-page":"42","article-title":"Coley toxins immunotherapy: a retrospective review","volume":"5","author":"Richardson","year":"1999","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2005.01110.x","article-title":"Coley\u2019s toxin revisited: immunotherapy or plasminogen activator therapy of cancer?","volume":"3","author":"Zacharski","year":"2005","journal-title":"J ThrombHaemost"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/postgradmedj\/79.938.672","article-title":"Dr. William Coley and tumour regression: a place in history or in the future","volume":"79","author":"HoptionCann","year":"2003","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0040","first-page":"85","article-title":"Global burden of Cancer","volume":"79","author":"Ma","year":"2006","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0045","doi-asserted-by":"crossref","first-page":"100783","DOI":"10.1016\/j.apmt.2020.100783","article-title":"New horizons in benzothiazole scaffold for cancer therapy: advances in bioactivity, functionality, and chemistry","volume":"20","author":"Sharma","year":"2020","journal-title":"Appl Mater Today"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0050","first-page":"833","article-title":"Emerging insights into the biology of metastasis: a review article. Iran","volume":"22","author":"Irani","year":"2019","journal-title":"J. Basic Med. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1403494817715400","article-title":"The global cancer burden and human development: a review","volume":"46","author":"Fidler","year":"2017","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0060","doi-asserted-by":"crossref","first-page":"112016","DOI":"10.1016\/j.ejmech.2019.112016","article-title":"Thiazole-containing compounds as therapeutic targets for cancer therapy","volume":"188","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0065","doi-asserted-by":"crossref","DOI":"10.2174\/0929867328666210322103906","article-title":"Therapeutic potential of natural compounds in lung Cancer","volume":"28","author":"Al-Yozbaki","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0070","unstructured":"World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer 2021."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-021-00299-4","article-title":"Nanomedicine-based cancer immunotherapy: recent trends and future perspectives","author":"Lakshmanan","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0085","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/0284186X.2017.1348621","article-title":"Radiobiological issues in proton therapy","volume":"56","author":"Mohan","year":"2017","journal-title":"Acta Oncol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/0008-5472.CAN-07-6871","article-title":"Advances in radiotherapy and implications for the next century: a historical perspective","volume":"69","author":"Connell","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (Review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","article-title":"DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology","volume":"20","author":"Cheung-Ong","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0105","first-page":"377","article-title":"Non-Hodgkin lymphoma secondary to cancer chemotherapy","volume":"16","author":"Krishnan","year":"2007","journal-title":"Cancer EpidemBiomar Prev"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"Maroun","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0115","first-page":"5","article-title":"Cancer statistics 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0120","first-page":"495","article-title":"Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study","volume":"29","author":"Azam","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-018-0022-9","article-title":"The intracellular signalosome of PD-L1 in cancer cells","volume":"3","author":"Escors","year":"2018","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9585614","article-title":"Immunotherapies: Exploiting the Immune System for Cancer Treatment","author":"Koury","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/ijms19010210","article-title":"Galectin targeted therapy in oncology: current knowledge and perspectives","volume":"19","author":"Wdowiak","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cancers10010009","article-title":"Current advances in aptamers for Cancer diagnosis and therap","volume":"10","author":"Hori","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0145","first-page":"101","article-title":"New developments in neoadjuvant therapy for lung Cancer","volume":"33","author":"Jr Bunn","year":"2019","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0150","doi-asserted-by":"crossref","first-page":"a030635","DOI":"10.1101\/cshperspect.a030635","article-title":"Treatment of advanced prostate Cancer-A review of current therapies and future promise","volume":"8","author":"Sumanasuriya","year":"2017","journal-title":"Cold Spring HarbPerspect Med"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ph11020037","article-title":"Mechanism of the dual activities of human CYP17A1 and binding to anti-prostate Cancer drug abiraterone revealed by a novel V366M mutation causing 17,20 lyase deficiency","volume":"11","author":"Fern\u00e1ndez-Cancio","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tim.2005.01.002","article-title":"Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle","volume":"13","author":"Nougayrede","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0165","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0170","series-title":"Mechanisms of Microbial Disease","first-page":"162","article-title":"Bacterial toxins","author":"Schlessinger","year":"1993"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0175","doi-asserted-by":"crossref","first-page":"a013573","DOI":"10.1101\/cshperspect.a013573","article-title":"General aspects and recent advances on bacterial protein toxin","volume":"3","author":"Lemichez","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/339394a0","article-title":"A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin","volume":"339","author":"Chaudhary","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0185","series-title":"The Comprehensive Sourcebook of Bacterial Protein Toxins","author":"Alouf","year":"2015"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1423-0127-17-21","article-title":"Bacteria in cancer therapy: a novel experimental strategy","volume":"17","author":"Patyar","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/toxins9080236","article-title":"Bacterial toxins for cancer therapy","volume":"9","author":"Zahaf","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0200","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.3390\/ijms21207575","article-title":"Microbes as medicines: harnessing the power of Bacteria in advancing Cancer treatment","volume":"21","author":"Sawant","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0205","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/cam4.2148","article-title":"Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities","volume":"8","author":"Sedighi","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0210","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.171.5.2197","article-title":"Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen","volume":"171","author":"Denkberg","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0215","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3389\/fmicb.2019.02340","article-title":"Targeted diphtheria toxin based therapy: a review article","volume":"10","author":"Shafiee","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317692226","article-title":"Immunotoxin: A new tool for cancer therapy","volume":"39","author":"Allahyari","year":"2017","journal-title":"Tumor. Biol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0225","first-page":"570","article-title":"Immunotoxins in cancer therapy","volume":"11","author":"Kreitman","year":"1999","journal-title":"CurrOpin Immunol"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08830185.2017.1284211","article-title":"Immunotoxins in cancer therapy: review and update","volume":"36","author":"Akbari","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0235","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2018.04.003","article-title":"Promoter-operating targeted expression of gene therapy in cancer: current stage and prospect","volume":"11","author":"Chen","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3332\/ecancer.2017.751","article-title":"Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy","volume":"11","author":"Javan","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0245","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1158\/0008-5472.CAN-05-2782","article-title":"Claudin proteins in human cancer: promising new targets for diagnosis and therapy","volume":"65","author":"Morin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00262-009-0794-4","article-title":"Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin","volume":"59","author":"Sarnovsky","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04814-4","article-title":"Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients","volume":"9","author":"Ji","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0260","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/iai.62.3.956-960.1994","article-title":"Cytotoxicity of a shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells","volume":"62","author":"Al-Jaufy","year":"1994","journal-title":"Infect immune"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0265","article-title":"\"Apoptosis and Necrosis on T47D Cells Induced by Shiga-Like Toxin from Local Isolates of Escherichia coli O157: H7","author":"Suardana","year":"2018","journal-title":"Preprints"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0270","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2147\/IJN.S127575","article-title":"Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential","volume":"12","author":"Yu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0275","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3389\/fimmu.2020.01261","article-title":"Immunogenicity of immunotoxins containing pseudomonas exotoxin a: causes, consequences, and mitigation","volume":"11","author":"Mazor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0280","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00018-017-2487-z","article-title":"Microbial carcinogenic toxins and dietary anti-cancer protectants","volume":"74","author":"Trevor","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid0502.990206","article-title":"Bacterial toxins: friends or foes?","volume":"5","author":"Schmitt","year":"1999","journal-title":"Emerg infect Dis"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-018-0138-z","article-title":"Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy","volume":"13","author":"Krueger","year":"2019","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0295","first-page":"1","article-title":"Toxins from bacteria","volume":"100","author":"Henkel","year":"2010","journal-title":"EXS."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0300","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/cddis.2013.540","article-title":"Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins","volume":"5","author":"Bachran","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.29252\/pbp.2.1.26","article-title":"The role of bacteria in the treatment of cancer: a comprehensive review","volume":"2","author":"Khadem","year":"2020","journal-title":"Plant Biotechnol Persa"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0310","first-page":"265","article-title":"Expression of synaptic vesicle protein 2a in epilepsy-associated brain tumors and in the peritumoral cortex","volume":"12","author":"de Groot","year":"2010","journal-title":"NeuroOncol"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/femspd\/ftv105","article-title":"Bacterial protein toxins in human cancers","volume":"74","author":"Rosadi","year":"2016","journal-title":"FEMS Pathog Dis"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0320","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00018-017-2487-z","article-title":"Microbial carcinogenic toxins and dietary anti-cancer protectants","volume":"74","author":"Stone","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0325","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41575-020-0303-y","article-title":"Microbiota and colorectal cancer: colibactin makes its mark","volume":"17","author":"Arthur","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1574-6968.2001.tb10832.x","article-title":"Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation?","volume":"203","author":"De Rycke","year":"2001","journal-title":"FEMS Microbial Lett"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0335","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0722.2004.00157.x","article-title":"Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro","volume":"112","author":"Yamamoto","year":"2004","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fcimb.2017.00223","article-title":"Cytolethal distending toxin enhances radiosensitivity in prostate cancer cells by regulating autophagy","volume":"7","author":"Lin","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0345","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(78)90099-5","article-title":"One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell","volume":"15","author":"Yamaizumi","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0350","first-page":"4042","article-title":"Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia","volume":"49","author":"Kiyokawa","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2017.05.008","article-title":"Ontak-like human IL-2 fusion toxin","volume":"448","author":"Wang","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0360","first-page":"1004","article-title":"Phase I trial of a novel diphtheria toxin\/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia","volume":"8","author":"Frankel","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0365","first-page":"7878","article-title":"Expression of Clostridium perfringens enterotoxin receptors claudin\u20103 and claudin\u20104 in prostate cancer epithelium","volume":"61","author":"Long","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0370","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-10-1644","article-title":"C-Terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to taxol and carboplatin","volume":"17","author":"Gao","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0375","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/104063870701900208","article-title":"Clostridium perfringens type A toxin production in 3 commonly used culture media","volume":"19","author":"Fernandez-Miyakawa","year":"2007","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0380","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/MMBR.00062-12","article-title":"Toxin plasmids of Clostridium perfringens","volume":"77","author":"Li","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/1878-0261.12615","article-title":"Targeting claudin\u2010overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin","volume":"14","author":"Piontek","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/iai.9.1.113-118.1974","article-title":"Purification and characterization of Pseudomonas aeruginosa exotoxin","volume":"9","author":"Callahan","year":"1974","journal-title":"Infect. Immun."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/bc00013a010","article-title":"Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin","volume":"3","author":"Kreitman","year":"1992","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0400","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/S0021-9258(17)37331-3","article-title":"Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner","volume":"269","author":"Kuan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0405","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/1078-0432.CCR-08-1456","article-title":"CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies","volume":"15","author":"Alderson","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0410","first-page":"693","article-title":"Hairy cell leukemia, a B-cell neoplasm which is particularly sensitive to the cytotoxic effect of anti-Tac (Fv)-PE38 (LMB-2)","volume":"6","author":"Robbins","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0415","first-page":"1008","article-title":"Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice","volume":"54","author":"Phillips","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0420","doi-asserted-by":"crossref","first-page":"37550","DOI":"10.18632\/oncotarget.17197","article-title":"Anti-tumor activity of an immunotoxin (TGF\u03b1-PE38) delivered by attenuated Salmonella typhimurium","volume":"8","author":"Lim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0425","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/07357907.2019.1655761","article-title":"Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines","volume":"37","author":"Amoozadeh","year":"2019","journal-title":"Cancer Invest."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0430","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5483\/BMBRep.2019.52.8.250","article-title":"A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells","volume":"52","author":"Lee","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/13543784.16.2.209","article-title":"Use of botulinum toxins in cancer therapy","volume":"16","author":"Ansiaux","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0440","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/toxins5061140","article-title":"Staphylococcus aureus \u03b1-Toxin: nearly a century of intrigue","volume":"5","author":"Berube","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0445","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm.2451","article-title":"A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice","volume":"17","author":"Inoshima","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09687689709068435","article-title":"Membrane insertion: the strategies of toxins (review)","volume":"14","author":"Lesieur","year":"1997","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0455","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/gt.2008.188","article-title":"Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors","volume":"16","author":"Ryan","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0460","first-page":"2615","article-title":"Cholera toxin triggers apoptosis in human lung Cancer cell lines","volume":"57","author":"Allam","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0465","doi-asserted-by":"crossref","first-page":"13438","DOI":"10.1073\/pnas.0701990104","article-title":"Cholera toxin induces malignant glioma cell differentiation via the PKA\/CREB pathway","volume":"104","author":"Li","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0470","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1128\/IAI.67.9.4393-4399.1999","article-title":"1,3 Characterization of Binding of Adenylate Cyclase Toxin to Target Cells by Flow Cytometry","volume":"67","author":"Gray","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0475","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.193.9.1035","article-title":"The Adenylate Cyclase Toxin of Bordetella pertussis Binds to Target Cells via the \u25a1M\u03b22 Integrin (CD11b\/CD18)","volume":"193","author":"Guermonprez","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0480","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/954375","article-title":"Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets","author":"Stachowiak","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0485","doi-asserted-by":"crossref","first-page":"e32310","DOI":"10.1371\/journal.pone.0032310","article-title":"Listeriolysin O is strongly immunogenic independently of its cytotoxic activity","volume":"7","author":"Carrero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0490","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tranon.2018.01.019","article-title":"Safety of therapeutic fever induction in cancer patients using approved PAMP drugs","volume":"11","author":"Reuter","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0495","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-5876-7-69","article-title":"Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences","volume":"7","author":"Mizrahi","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0500","first-page":"178174","article-title":"Use of H19 gene regulatory sequences in DNA-based therapy for pancreatic cancer","volume":"1","author":"Scaiewicz","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0505","doi-asserted-by":"crossref","first-page":"e20760","DOI":"10.1371\/journal.pone.0020760","article-title":"Aerosolized bc-819 inhibits primary but not secondary lung cancer growth","volume":"6","author":"Hasenpusch","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0510","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdcr.2017.06.031","article-title":"Primary cutaneous anaplastic large-cell lymphoma: complete remission for 13 years after denileukindiftitox","volume":"3","author":"Lewis","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0515","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1158\/1535-7163.MCT-05-0515","article-title":"Suicide cancer gene therapy using pore-forming toxin","volume":"5","author":"Yang","year":"2006","journal-title":"streptolysin O. Mol Cancer Ther"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0520","first-page":"31","article-title":"Targeting MCF-7 cell line by listeriolysin O pore forming toxin fusion with AHNP targeted peptide","volume":"8","author":"Fotoohi-Ardakani","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0525","first-page":"6516","article-title":"Antitumor therapy with bacterial DNA and toxin: complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus Interleukin-13 cytotoxin","volume":"9","author":"Ishii","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0530","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1099\/jmm.0.000003","article-title":"Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines","volume":"64","author":"Goldufsky","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0535","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/carcin\/bgu325","article-title":"Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer","volume":"36","author":"Doulberis","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0540","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00262-002-0288-0","article-title":"Protein A-induced apoptosis of cancer cells is effected by soluble immune mediators Cancer","volume":"51","author":"Das","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0545","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1083\/jcb.200105081","article-title":"Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling","volume":"155","author":"Bantel","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0550","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","article-title":"Secondary necrosis: the natural outcome of the complete apoptotic program","volume":"584","author":"Silva","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0555","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5301\/RU.2012.9254","article-title":"Botulinum toxin type-A toxin activity on prostate cancer cell lines","volume":"79","author":"Proietti","year":"2012","journal-title":"Urologia"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0560","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pharmaceutics10020054","article-title":"Anticancer activity of bacterial proteins and peptides","volume":"10","author":"Karpinski","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0565","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7314\/APJCP.2013.14.2.891","article-title":"Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line","volume":"14","author":"Bandala","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0570","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1158\/0008-5472.CAN-05-1022","article-title":"HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor","volume":"65","author":"Lokeshwar","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0575","series-title":"99th AACR Annual Meeting San Diego","first-page":"12","article-title":"In vitro studies on anti-cancer effect of streptococcus pyogenes phage hyaluronidase (HylP) on breast cancer","author":"Lee","year":"2008"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0580","first-page":"1","article-title":"In vitro analysis of the anticancer activity of Lysinibacillussphaericus binary toxin in human cancer cell lines","volume":"10","author":"Chankamngoen","year":"2020","journal-title":"Biotech"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0585","series-title":"Microbial Diversity and Biotechnology in Food Security","first-page":"513","article-title":"Fungal toxins and their impact on living systems","author":"Singh","year":"2014"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0590","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/agriculture5030492","article-title":"Mycotoxins: producing fungi and mechanisms of phytotoxicity","volume":"5","author":"Ismaiel","year":"2015","journal-title":"Agriculture"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0595","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.toxlet.2004.04.024","article-title":"Haematotoxicity of trichothecenes","volume":"153","author":"Parent-Maain","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0600","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/384223a0","article-title":"Genes from wild rice improve yield","volume":"384","author":"Xiao","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0605","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/CMR.16.3.497-516.2003","article-title":"Mycotoxins","volume":"16","author":"Bennett","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0610","first-page":"31","article-title":"Mycotoxin: An alternate source of anticancer drug","volume":"2","author":"Nascar","year":"2015","journal-title":"Int Res J Phamaceut Biosci"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0615","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/19440049.2010.546000","article-title":"Recent research on fumonisins: a review","volume":"29","author":"Scott","year":"2012","journal-title":"FoodAdditContam Part A Chem Anal Control Expo Risk Assess"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0620","doi-asserted-by":"crossref","first-page":"39627","DOI":"10.18632\/oncotarget.8914","article-title":"Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0625","first-page":"191","article-title":"New insights into mycotoxin mixtures: the toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic","volume":"272","author":"Alassane-Kpembi","year":"2013","journal-title":"ToxicolAppl Pharmacol"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0630","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/1541-4337.12287","article-title":"Current immunoassay methods for the rapid detection of aflatoxin in milk and dairy products","volume":"16","author":"Matabaro","year":"2017","journal-title":"ComprRev Food Sci Food Saf"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0635","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/toxins9040113","article-title":"A review: epigenetic mechanism inochratoxin a toxicity studies","volume":"9","author":"Zhu","year":"2017","journal-title":"Toxins"},{"issue":"10 HCC","key":"10.1016\/j.semcancer.2021.07.007_bib0640","doi-asserted-by":"crossref","first-page":"e7238","DOI":"10.5812\/hepatmon.7238","article-title":"The role of aflatoxins in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2012","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0645","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mehy.2015.11.026","article-title":"The case for aflatoxins in the causal chain of gallbladder cancer","volume":"86","author":"Foerster","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0650","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/toxins8040111","article-title":"Ochratoxin A: molecular interactions, mechanisms of toxicity and prevention at the molecular level","volume":"8","author":"K\u0151szegi","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0655","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/ijerph110201855","article-title":"Mycotoxins\u2019 activity at toxic and sub-toxic concentrations: differential cytotoxic and genotoxic effects of single and combined administration of sterigmatocystin, ochratoxin A and citrinin on the hepatocellular cancer cell line Hep3B","volume":"11","author":"Anninou","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0660","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2013.07.026","article-title":"Cytotoxicity and phytotoxicity of trichothecene mycotoxins produced by Fusarium spp","volume":"74","author":"Abbas","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0665","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1039\/C6RA26956G","article-title":"Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus Stachybotryschartarumwith tyrosine kinase inhibition","volume":"7","author":"Li","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0670","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1021\/jf200767q","article-title":"T-2 toxin, a trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods","volume":"59","author":"Li","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0675","doi-asserted-by":"crossref","first-page":"111473","DOI":"10.1016\/j.fct.2020.111473","article-title":"Cytotoxic effects of individual and combined sterigmatocystin and nivalenol on liver hepatocellular carcinoma cells","volume":"143","author":"Zingales","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0680","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.toxlet.2018.07.007","article-title":"Response of intestinal HT-29 cells to the trichothecene mycotoxin deoxynivalenol and its sulfated conjugates","volume":"295","author":"Del Favero","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0685","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/toxins6051615","article-title":"Effect of deoxynivalenol and other Type B trichothecenes on the intestine: a review","volume":"6","author":"Pinton","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0690","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/toxins11050265","article-title":"Deoxynivalenol modulates the viability, ROS production and apoptosis in prostate cancer cells","volume":"11","author":"Habrowska-G\u00f3rczy\u0144ska","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0695","first-page":"11","article-title":"The occurrence, properties and significance of citrinin mycotoxin","volume":"6","author":"Doughari","year":"2015","journal-title":"Plant Pathol Microbiol"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0700","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cellsig.2011.12.017","article-title":"Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation","volume":"24","author":"Kwon","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0705","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kfu319","article-title":"Patulin induces apoptosis through ROS-Mediated endoplasmic reticulum stress pathway","volume":"144","author":"Boussabbeh","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0710","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.3390\/md13095657","article-title":"Marine compoundsand cancer: where do we stand?","volume":"13","author":"Dyshlovoy","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0715","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/md16050165","article-title":"Marine microalgae with anti-cancer properties","volume":"16","author":"Mart\u00ednez Andrade","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0720","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0025315415002106","article-title":"The marine biodiscovery pipeline and ocean medicines of tomorrow","volume":"96","author":"Jaspars","year":"2016","journal-title":"J. Mar. Biol. Assoc. U.K."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0725","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/toxins2102359","article-title":"Diversity and impact of prokaryotic toxins on aquatic environments: a review","volume":"2","author":"Val\u00e9rio","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0730","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.chemosphere.2016.05.051","article-title":"PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway","volume":"157","author":"Ma","year":"2016","journal-title":"Chemosphere"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0735","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/md8030629","article-title":"Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs","volume":"8","author":"Sainis","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0740","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopha.2018.12.069","article-title":"Microalgae in modern cancer therapy: current knowledge","volume":"111","author":"Abd El-Hack","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0745","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-12-387669-0.00016-8","article-title":"Anticancer compounds from marine macroalgae and their application as medicinal foods","volume":"64","author":"Kim","year":"2011","journal-title":"Adv. Food Nutr. Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0750","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1472-8206.2009.00669.x","article-title":"Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1,2-dimethyl hydrazine-induced experimental colon carcinogenesis","volume":"23","author":"Prabhu","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0755","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12906-017-1611-9","article-title":"Chlorella sorokiniana induces mitochondrial-mediated apoptosis in human non-small cell lung cancer cells and inhibits xenograft tumor growth in vivo","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0760","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0706741","article-title":"Grateloupialongifolia polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC-1 endothelial cells","volume":"148","author":"Zhang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0765","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/carcin\/bgs396","article-title":"Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFbeta receptor degradation in breast cancer","volume":"34","author":"Hsu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0770","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1038\/ncomms14292","article-title":"Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma","volume":"8","author":"Mizrachi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0775","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2018.05.006","article-title":"Fucoidan upregulates TLR4\/CHOP-mediated caspase- 3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells","volume":"432","author":"Hsu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0780","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/md17010032","article-title":"Fucoidan structure and activity in relation to anti-cancer mechanisms","volume":"17","author":"Van Weelden","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0785","series-title":"The Role of Synthesis and Biosynthetic Logic","first-page":"559","author":"Ding","year":"2010"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0790","doi-asserted-by":"crossref","first-page":"112364","DOI":"10.1016\/j.ejmech.2020.112364","article-title":"Cryptophycin-55\/52 based antibody-drug conjugates: synthesis, efficacy, and mode of action studies","volume":"199","author":"Lai","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0795","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2174\/0929867043364504","article-title":"Sulfated seaweed polysaccharides as antiviral agents","volume":"18","author":"Damonte","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0800","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.intimp.2008.12.010","article-title":"Characterization and anti-tumor activity ofalkali-extracted polysaccharide from Enteromorphaintestinalis","volume":"9","author":"Jiao","year":"2009","journal-title":"Int Immuno Pharmacol"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0805","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/glycob\/cwm014","article-title":"A comparative study of the antiinflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds","volume":"17","author":"Cumashi","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0810","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.xphs.2019.10.037","article-title":"Critical issues in the development of immunotoxins for anticancer therapy","volume":"109","author":"Kim","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0815","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14712598.2019.1614558","article-title":"Moxetumomabpasudotox for the treatment of hairy cell leukemia","volume":"19","author":"Janus","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0820","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40265-019-01087-z","article-title":"Tagraxofusp: first global approval","volume":"79","author":"Syed","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0825","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jps.23343","article-title":"Pharmacokinetic and pharmacodynamic comparability study of moxetumomabpasudotox, an immunotoxin targeting CD22, in cynomolgus monkeys","volume":"102","author":"Wang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0830","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0835","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.1815087116","article-title":"Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma","volume":"116","author":"Cheung","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0840","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2397808","article-title":"Microorganisms in the treatment of cancer: advantages and limitations","author":"\u0141ukasiewicz","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0845","unstructured":"Bermudes DG. Modified bacteria having improved Pharmacokinetics and tumor Colonization enhancing antitumor Activity. US10,449,237 B1, Oct. 22, 2019."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0850","unstructured":"Newman MJ.Compositions and methods for treatment of cancerusingbacteria.US9,265,804 B2, Feb. 23, 2016."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0855","unstructured":"Collier RJ, PenteluteBL.Method for deliveringagents into cells using bacterial toxins.US9,079,952 B2,Jul. 14, 2015."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0860","unstructured":"Chapman E.R., Yeh F.L., Method for selective targeting and entry of bacterial toxins to cells. 2015\/0283261 A1, Oct. 8, 2015."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0865","unstructured":"Davis C.G., Datta D., Baker M.P., Rust A.J.,Keen S.Modified toxins. US8,252,897 B2, Aug. 28, 2012."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0870","unstructured":"Masignani V., Pizza M., Rappuoli R. ADP-ribosylating bacterial toxins. US7,928,192 B2,Apr. 19, 2011."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0875","unstructured":"Taylor B.N., Mehta R., Yamada T., Beattie C., Gupta TD. Compositions and methods to prevent cancer with cupredoxins. US2009\/0202441 A1, Aug. 13, 2009."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0880","unstructured":"Chun-Lap Lo S., Chan L.L.,Hodgkiss I.J., Bomarkers for toxic algae. US2008\/0248482 A1,Oct. 9, 2008."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0885","unstructured":"Sawamura S., Nishimura M., Sakane I., Neutralizingagent for clostridium bacterial neurotoxins and preparation method thereof. US6,987,126 B2, Jan. 17, 2006."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0890","unstructured":"Blake M.S., Bogdan JR. JA,Nazario-Larrieu J. Method for the production of bacterial toxins. US2006\/0216789 A1, Sep. 28, 2006."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0895","unstructured":"Kaufmann DA. Method of treating and preventing cancer. US2005\/0049207 A1, Mar. 3, 2005."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0900","unstructured":"Powers LS, Ellis Jr. WR, Lloyd CR.Taxonomic identification of pathogenic microorganisms and ther toxic proteins. US6, 780,602 B2, Aug. 24, 2004."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0905","doi-asserted-by":"crossref","unstructured":"Donovan S. Method for treating cancer with a neurotoxin. US6,139,845, Oct. 31, 2000.","DOI":"10.1007\/978-1-4471-0769-9_371"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0910","unstructured":"Keusch G.T., Donohue-Rolfe A., Acheson D.W.K. Assays for shigatoxin and shiga like toxins. US5,955,293, Sep. 21, 1999."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0915","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-micro-092412-155725","article-title":"Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells","volume":"68","author":"Gal\u00e1n","year":"2014","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0920","article-title":"Mechanisms of cyanotoxin toxicity-carcinogenicity, anticancer potential, and clinical toxicology","author":"Vankova","year":"2019","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0925","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biomedicines5020028","article-title":"Addressing the immunogenicity of the cargo and of the targeting antibodies with a focus on demmunized bacterial toxins and on antibody-targeted human effector proteins","volume":"5","author":"Grinberg","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.semcancer.2021.07.007_bib0930","article-title":"Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers","author":"Kashyap","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0935","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijbiomac.2019.12.145","article-title":"Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics","volume":"145","author":"Ashrafizadeh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2021.07.007_bib0940","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8010013","article-title":"Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics","volume":"8","author":"Shakeri","year":"2020","journal-title":"Biomedicines"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:24:41Z","timestamp":1760919881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":188,"alternative-id":["S1044579X21002017"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.007","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in microbial toxin-related strategies to combat cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}